Detalhe da pesquisa
1.
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.
Blood
; 141(13): 1610-1625, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508699
2.
HSV-1 ICP27 targets the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression.
EMBO J
; 35(13): 1385-99, 2016 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27234299
3.
Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development.
Genes Dev
; 24(9): 875-80, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20439428
4.
Monosodium urate activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional protein secretion from human primary macrophages.
Mol Cell Proteomics
; 12(3): 749-63, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23292187
5.
Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling.
Oncogenesis
; 13(1): 11, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429288
6.
Robust scoring of selective drug responses for patient-tailored therapy selection.
Nat Protoc
; 19(1): 60-82, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996540
7.
Global secretome characterization of herpes simplex virus 1-infected human primary macrophages.
J Virol
; 86(23): 12770-8, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22973042
8.
Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures.
Cancers (Basel)
; 15(15)2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568580
9.
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes.
Signal Transduct Target Ther
; 8(1): 80, 2023 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843114
10.
Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen.
Cells
; 11(9)2022 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35563880
11.
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia.
Sci Transl Med
; 14(650): eabn3248, 2022 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731890
12.
The Peptide-Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death.
Hemasphere
; 6(3): e687, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243210
13.
Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches.
Proteomes
; 9(4)2021 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34842843
14.
Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen.
Cancers (Basel)
; 13(7)2021 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33810334
15.
S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma.
Front Cell Dev Biol
; 9: 723016, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485305
16.
Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma.
Blood Adv
; 5(20): 4125-4139, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478517
17.
Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts.
Nat Cell Biol
; 10(5): 527-37, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18425119